KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Gains from Investment Securities (2016 - 2025)

CareDx's Gains from Investment Securities history spans 13 years, with the latest figure at $12.2 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 30.41% year-over-year to $12.2 million; the TTM value through Dec 2025 reached $12.1 million, up 20.11%, while the annual FY2025 figure was $12.1 million, 20.11% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $12.2 million at CareDx, up from -$9.4 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $12.2 million in Q4 2025 and bottomed at -$9.4 million in Q3 2025.
  • The 5-year median for Gains from Investment Securities is $7000.0 (2025), against an average of $1.2 million.
  • The largest YoY upside for Gains from Investment Securities was 9642.86% in 2024 against a maximum downside of 4533.33% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$559000.0 in 2021, then skyrocketed by 245.97% to $816000.0 in 2022, then decreased by 8.33% to $748000.0 in 2023, then surged by 1147.46% to $9.3 million in 2024, then skyrocketed by 30.41% to $12.2 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Gains from Investment Securities are $12.2 million (Q4 2025), -$9.4 million (Q3 2025), and $9.3 million (Q2 2025).